Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
MusclePharm Corp (0001415684)
Standardized SEC financial data for MusclePharm Corp — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001415684 · Pharmaceutical Preparations.
Gross margin
10.7%
Operating margin
-17.8%
Net margin
-25.7%
Revenue growth (YoY)
-22.3%
Return on equity
40.0%
ROIC
-1000.0%
Free cash flow
-$8.0M
Debt / equity
-1.06×
Ratios for fiscal year 2021, standardized from SEC filings.